Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Picchio

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Clinical Nuclear Medicine|May 29, 2015
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone PlasmacytomasPierpaolo Alongi, Lucia Zanoni, Elena Incerti, et al.
Urologic Oncology|June 18, 2013
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated seriesNiccolò M Passoni, Nazareno Suardi, Firas Abdollah, et al.
Lancet (London, England)|August 29, 2003
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year resultsUgo Pastorino, Massimo Bellomi, Claudio Landoni, et al.
European Urology|February 7, 2016
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the LiteratureLaura Evangelista, Alberto Briganti, Stefano Fanti, et al.
Nuclear Medicine Communications|December 4, 2018
Sensitivity of fluorine-18-fluoromethylcholine PET/CT to prostate-specific antigen over different plasma levels: a retrospective study in a cohort of 192 patients with prostate cancerGiampiero Giovacchini, Elisabetta Giovannini, Elisa Borsò, et al.
Clinical Nuclear Medicine|April 26, 2020
Hypoxia and Amino Acid Imaging of High-Grade Glioma: 18F-FAZA PET/CT and 11C-Methionine PET/MRIPaola Mapelli, Federico Fallanca, Paola Scifo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2006
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrenceSandro Sironi, Maria Picchio, Claudio Landoni, et al.
Clinical Nuclear Medicine|December 19, 2008
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experienceGiampiero Giovacchini, Federico Fallanca, Claudio Landoni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2013
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancerSilvia Valtorta, Sara Belloli, Francesca Sanvito, et al.
Gynecologic Oncology|August 23, 2011
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?Mauro Signorelli, Luca Guerra, Luca Montanelli, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Clinical Nuclear Medicine|May 29, 2015
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone PlasmacytomasPierpaolo Alongi, Lucia Zanoni, Elena Incerti, et al.
Urologic Oncology|June 18, 2013
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated seriesNiccolò M Passoni, Nazareno Suardi, Firas Abdollah, et al.
Lancet (London, England)|August 29, 2003
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year resultsUgo Pastorino, Massimo Bellomi, Claudio Landoni, et al.
European Urology|February 7, 2016
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the LiteratureLaura Evangelista, Alberto Briganti, Stefano Fanti, et al.
Nuclear Medicine Communications|December 4, 2018
Sensitivity of fluorine-18-fluoromethylcholine PET/CT to prostate-specific antigen over different plasma levels: a retrospective study in a cohort of 192 patients with prostate cancerGiampiero Giovacchini, Elisabetta Giovannini, Elisa Borsò, et al.
Clinical Nuclear Medicine|April 26, 2020
Hypoxia and Amino Acid Imaging of High-Grade Glioma: 18F-FAZA PET/CT and 11C-Methionine PET/MRIPaola Mapelli, Federico Fallanca, Paola Scifo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2006
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrenceSandro Sironi, Maria Picchio, Claudio Landoni, et al.
Clinical Nuclear Medicine|December 19, 2008
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experienceGiampiero Giovacchini, Federico Fallanca, Claudio Landoni, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2013
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancerSilvia Valtorta, Sara Belloli, Francesca Sanvito, et al.
Gynecologic Oncology|August 23, 2011
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?Mauro Signorelli, Luca Guerra, Luca Montanelli, et al.
Pageof 19